ERB-041, a selective ERβ agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-κB activation

article OA: closed CC0 ⤵ 16 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-07

ERB-041, a selective ERβ agonist, was found to inhibit inducible nitric oxide synthase (iNOS) production in lipopolysaccharide (LPS)-activated peritoneal macrophages from endometriosis patients by suppressing NF-κB activation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Anti-Inflammatory Agents, Non-Steroidal Endometriosis Estrogen Receptor beta Macrophages, Peritoneal NF-kappa B Nitric Oxide Synthase Type II Oxazoles Anti-Inflammatory Agents, Non-Steroidal Cells, Cultured Endometriosis Endometriosis Endometriosis Estrogen Receptor beta Estrogen Receptor beta Extracellular Signal-Regulated MAP Kinases Extracellular Signal-Regulated MAP Kinases Female Humans Lipopolysaccharides Lipopolysaccharides

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Cited by (16)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:14:05.573375+00:00
License: CC0 · commercial use OK